Barely Significant
← all excerpts

The effect of empagliflozin on growth differentiation factor 15 in patients with heart failure: a randomized controlled trial (Empire HF Biomarker).

Cardiovasc Diabetol · 2022 · PMC8882292 · PMID 35219331

Europe PMCDOI
1
hedged sentence
0.0520
closest p · 1.0× alpha
0.0520
boldest claim

The sentences

borderline significantp = 0.052so close (0.05 < p ≤ 0.1)
Finally, there was a borderline significant association between the increase in plasma GDF-15 with the decrease in systolic blood pressure from baseline to follow-up ( R = – 0.20, p = 0.052) (Table 3 ).

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.